SCHEMBL20962650

SCHEMBL20962650

CSN1CCN(C(=O)CC2CC2)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NAMPT P43490 2/20 0.51
▸ TPSAB1 Q15661 1/20 0.38
▸ TPSD1 Q9BZJ3 1/20 0.38
▸ TPSG1 Q9NRR2 1/20 0.38
▸ ALDH1A1 P00352 4/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ CNR2 P34972 1/20 0.37
▸ OPRM1 P35372 1/20 0.37
▸ OPRL1 P41146 1/20 0.37
▸ CYP1A2 P05177 1/20 0.36
▸ CHRM4 P08173 1/20 0.36
▸ SMYD3 Q9H7B4 1/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ HSD11B1 P28845 1/20 0.35
▸ ATM Q13315 1/20 0.34
▸ TP53 P04637 1/20 0.33
▸ ADAM10 O14672 1/20 0.33
▸ ERBB2 P04626 1/20 0.33
▸ MMP2 P08253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24308808 0.89 NAMPT (0.42) NAMPTTPSAB1TPSD1TPSG1ALDH1A1
SCHEMBL24308809 0.82 NAMPT (0.40) NAMPTTPSAB1TPSD1TPSG1HSD17B10
SCHEMBL19195102 0.80 AKR1C3 (0.38) ALDH1A1KDM4EHSD17B10NPC1HSD11B1
SCHEMBL16838103 0.79 NAMPT (0.56) NAMPTTPSAB1TPSD1TPSG1ALDH1A1
SCHEMBL3711838 0.76 NAMPT (0.56) NAMPTTPSAB1TPSD1TPSG1ALDH1A1
SCHEMBL20328000 0.76 HSD11B1 (0.58) NAMPTTPSAB1TPSD1TPSG1ALDH1A1
SCHEMBL15076642 0.75 NAMPT (0.51) NAMPTTPSAB1TPSD1TPSG1ALDH1A1
SCHEMBL20084011 0.75 NAMPT (0.51) NAMPTTPSAB1TPSD1TPSG1ALDH1A1
SCHEMBL20970620 0.75 NAMPT (0.51) NAMPTTPSAB1TPSD1TPSG1ALDH1A1
SCHEMBL13451572 0.75 ALDH1A1 (0.62) NAMPTTPSAB1TPSD1TPSG1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190127374-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS ARRAY BIOPHARMA INC (US) 2019-05-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190127374-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS RET, ROR1, BRAF NAMPT 3149/4885TPSAB1 3441/4885TPSD1 2435/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback